Document Detail


An overview on the development of a bio-artificial pancreas as a treatment of insulin-dependent diabetes mellitus.
MedLine Citation:
PMID:  16342061     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This paper presents the concept and most of the research undertaken all over the world for the development of a bio-artificial pancreas (BAP) device over the last 30 years. The devices studied, meant to mimic the insulin secretion of the natural organ, were diverse and have been reviewed. Allogeneic or xenogeneic cells or cell clusters have been separated from the host's immune system by synthetic biocompatible semipermeable membranes to prevent the need, of the host, for immune-suppressing regimens. The biocompatible polymer used as a barrier and its intrinsic characteristics, the cell immobilization or suspension media, the existence or not of co-immobilized molecules or cells, the number of devices used and the implantation site, were addressed.
Authors:
Ana Isabel Silva; António Norton de Matos; I Gabrielle Brons; Marília Mateus
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Medicinal research reviews     Volume:  26     ISSN:  0198-6325     ISO Abbreviation:  Med Res Rev     Publication Date:  2006 Mar 
Date Detail:
Created Date:  2006-01-30     Completed Date:  2006-06-20     Revised Date:  2007-03-22    
Medline Journal Info:
Nlm Unique ID:  8103150     Medline TA:  Med Res Rev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  181-222     Citation Subset:  IM    
Copyright Information:
(c) 2005 Wiley Periodicals, Inc. Med Res Rev.
Affiliation:
Centro de Engenharia Biológica e Química, Instituto Superior Técnico, Lisboa, Portugal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acrylic Resins
Alginates / adverse effects
Animals
Bioartificial Organs*
Biocompatible Materials
Diabetes Mellitus, Type 1 / surgery*
Fibrosis / chemically induced
Graft Survival
Humans
Islets of Langerhans / metabolism
Islets of Langerhans Transplantation
Membranes, Artificial
Pancreas, Artificial*
Polylysine / adverse effects
Polyvinyl Chloride
Chemical
Reg. No./Substance:
0/Acrylic Resins; 0/Alginates; 0/Biocompatible Materials; 0/Membranes, Artificial; 25104-18-1/Polylysine; 55963-89-8/XM-50 Amicon; 9002-86-2/Polyvinyl Chloride

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A robust ratio metric method for analysis of Zap-70 expression in chronic lymphocytic leukemia (CLL)...
Next Document:  Flow-cytometric analysis of reactive oxygen species in peripheral blood mononuclear cells of patient...